Member Info for SocialistB

@HedgeHogarth.

I am very glad that I misunderstood your post, when I read it, it sounded like a wishful hope for a Management Buy Out. (MBO)

Regarding your question, if I were management, would I be tempted?

NO, no and no.

It would be so far away from my line of thinking.

I would feel like I had been screwing people over, who has taken a chance on me.

Especially with CBR in the pipeline.

And my take on Mr. Sandler is that his moral compass is also tilted in that direction.

And that is the reason that I have invested more than is advisable in this company.

I do not know 2 huts about the science and there is absolutely no way I could try and second guess if you just add a pinch of this and a pinch of that and then wave a magic wand, then you'll have a winning formula against XYZ.

So since I can't do that I can only go by my take on Mr. Sandler himself.

This is the man that is smart enough to discover HU-PHEG and capable of attracting big names to work with him.

But my main reason for having over-extended myself here is my read on Mr. Sandler's moral compass.

What others have seen as arrogance, I have often seen as honesty and a desire to create a cure.

And that is most important to me.

As I strongly believe, get the science right and the money will follow (if there is a market, obviously)

And we as shareholders will be rewarded.

If there was a MBO, we shareholders would not be rewarded.

And my take is that that would go against Mr. Sandler's moral compass.

And Hemotruth has a very good point when asking where would the money come from to progress the science, let alone buy the company?

Moving in that direction would upset me in ways I can not describe.

@ HedgeHogarth

Please tell me that your account have been hacked or you are delivering this April fools joke very late. (Better late then never I guess)

I simply cannot get my head around your 10.29 post about a management buy out.

I would feel totally and utterly taken advantage off.

Not that the plural in CBR's is a surprise.

What was a surprise is how much I liked that he said CBR in plural.

Obviously it's not dead.

It's fully alive and kicking.

I really cannot wait for the update.

Forget Hemo Car-T, I'm here for CBR.

(However I do not mind what Hemo Car-T will bring to the table) and hopefully especially for the long suffering Patients

@ Bline59

Thanks for the earworm mate:-)

Now I'll Olivia Newton-John singing in my head for the rest of the day.

@Archways

I'd like to chime in with the well wishing and a very sincere hope that as the very minimum you will experience the first ore coming out of the ground, as that would most likely have been the biggest milestone in your original 5 year plan.

But I hope that you will experience so much more then that. Both in regard to GGP and family life in general.

Some posters mentioned hope and innovation, and I think those 2 are very important to keep staying positive. So with the risk of being accused of cross ramping, may I suggest that if you got to much time on your hand, you look into the new CBR platform from Hemogenyx. I do not know if it would be applicable to your kind of cancer, and have to admit it is still very much in its infancy. But that is why it it is worth fighting every single day and make sure they turn into years.

Because years allows medicine to evolve and hopefully come up with a cure.

And I hope you'll again have the joy of adding several years to your lifespan and experience the behemoth that GGP will evolve to become.

And last but not least, more time with your loved ones.

@ConsDoms

I am not saying you are not right about the timeline when concluding the IND has been submitted to the FDA on Monday 8-5-2023, as this was not a bank holiday in the U.S.

But I'll argue that POTENTIALLY, just potentially the IND could already have been submitted Friday the 5-5-2023, after closing of the stock exchange here in London, but while everything is still in full swing on the east coast.

And we would still not have been informed about the IND application having been submitted any earlier then Tuesday the 9-5-2023 at 0700.

IF, that should happen to be the case, then the 30 days will end Sunday the 4-6-2023.

And again if that is the case, then we will wake up to a nice RNS on Monday the 5-6-2023

Against this theory goes the assumption that the FDA do not like to receive an application on a Friday.

Does Rio Tinto need Greatland Gold?

NO.

No is my simple answer to that question. They do not need Greatland Gold.

Nor do they need to sell up to 75% of a promising asset for peanuts.

Although, I doubt we will ever get to own more than 51% of the new company.

But that is still an incredible giveaway at an incredibly low price by Rio Tinto.

Don't get me wrong, it is nice that for once it is Greatland Gold that is doing a fantastic deal for peanuts.

But there must be a master plan behind this.

My take is that Rio Tinto would like to get in on the action in some of the other tenements that Greatland Gold owns.

And giving some of their own tenements up could be the price for consideration.

I most definitely see it as goodwill and am looking forward to working with them in the future.

@dhub at 10:23

I think you are onto something when you say: "That says it all really"

I bought a few shares today, and for that to happen there has to have been a seller.

So whoever that was: THANK YOU

I am pretty sure it was not dhub selling, although he was checking if it was possible to sell 6 million shares.

But of course, I cannot rule the possibility out completely, as it would demand information that I do not have.

What I can say with complete conviction, is that if dhub had in fact put 6 million shares up for sale, then the Market Maker would not have bought them of him, to fill my order.

So, there must be a big order out there, or several less big orders out there.

And if that is the case, then the share price staying at this level is nothing but games being played at this point.

@Cyrox

Isn't it a bit to early for that:-)

But they are most definitely somewhere else then here, so your suggestion is as good as any.

In fact I'll say it's the SHINIEST example I've seen today:-)

@Blastoid7

Thanks for reminding me about Sareum, I have not dealt with them for quite a while now.

As your pointing out, no traction despite a lot of action on the clinical front.

And that is the bit that worries me. It seems like the market has ZERO appetite for risky pharma stocks at the moment.

And if that is the case, then we will not see a rerate until the market believe we will get a cash flow.

But boy do I wish I am wrong about that and that JustHereForHemo is right and there will be a substantial rerate over the next 3 weeks.

But if that does not happen just like that, then the 3 main catalysts I see are:

FDA accelerate the approval of HEMO Car-T in the next couple of days.

(Yes, I know the difference is merely a few weeks, but the sign of approval should give the market confidence)

The market likes the partner Hemogenyx announces in the roll out of HEMO Car-T.

Patients has been signed up and clinical trials are about to commence.

With everything going for HEMOGENYX at the moment, and the news of the IND application out there, it beats me that there is no more traction in this share.

Where are all the risk takers, where are all the traders?

Where are all the investors that like a cheap company right on the cusp of significant changes?

@Hemotruth

The answer to your question is very simple.

There is not enough new investors with enough appetite to increase the share price.

Supply and demand in it's purest form.

Maybe it will increase a bit as we get closer to the 30th day after which we are likely to be clinical.

But as things stands at the moment, I do not expect the rerate we are all dreaming about until we are a clinical company.

And again, because it is as it is at the moment, I am questioning if the rerate will happen at that point, maybe it will first happen later when clinical trials start, or maybe even first later then that, when the first Patient is cured.

And if the rerate has not happened by then, then I might start to entertain various conspiracy theories:-)

@HedgeHogarth

I'd like to chime on here as well that I will miss your posts here.

And I'll urge you to reconsider setting up a forum on your own, as I am sure there could be unforseen legal liabilities that you'll have to contend with.

So better to just take a break from here and hopefully we'll see you here again soon.

But at that time, try not to engage with posters that comes across as potentially having ulterior motives of some sort.

Either way, thanks for many a great posts and all the best for the future.

Okay, so I had another go at finding out about the patent.

Have a look at this document:

https://wp-nanosynth-2021.s3.eu-west-2.amazonaws.com/media/2022/06/1._Nanosynth_Group_financial_statement_28.06_-ZAK-updated.pdf

Look at page 37, where they talk about the value of the intellectual property.

Or see page 31 where it states:

"Intellectual Property is amortised at 20% per annum on a straight-line basis. "

But maybe most importantly page 41 where it states:

"At acquisition Pharm 2 Farm Limited had rights over intellectual property under 15 year licences signed in 2019. "

To me that sounds like there is 11 years left on a licence.

A licence which could potentially be sold.

The question is if there is a buyer and not least if we as shareholders could be secured the right to a first dip?

@unitedguy

Thanks for the information Unitedguy.

Is it possible that you can post a link showing that Nottingham Trent University is the owner of the patent and that there is nothing that can be bought from the left over of NNN that can be of value in this regard.

I have just had a quick look but have not found anything.

It's my hope that you can save me a lot of time if you know exactly where to look.

Regarding taking class action, count me out.

Either things have rightfully gone wrong and there is nothing to address or if it is a deliberate act, then it is likely to have been covered up so well, that it will be hard to prove, as a wall of denial can be difficult to penetrate and not least prove.

Thanks in advance

I am shocked by today's announcement.

I had not seen it coming based on the RNS's released that talked about all the opportunities ahead of us.

And especially not after going to the AGM and talking to one of the members of BOD.

Yes, choppy waters ahead, but I expected nothing less from an AIM company in this development state.

But I did not expect this.

The only way I see we can salvage some value here is if club together and buy the Intellectual property.

I assume it is to be auctioned off.

Let's make that clear at the upcoming meeting that we think it is preferable that we as shareholders get the first dip on the intellectual property.

I think concerned shareholders should contact "ReSolve Advisory Limited" and ask about the possibility that we can acquire the intellectual property and what the price would be available.

@Mumbo_Jumbo

It could be as little as a fortnight.

But in reality, it is probably going to be longer.

They first have to get Patients and doctors who are willing to participate in the Phase I experiment.

Maybe they already have them lined up, but if they don't, then it will take the time it will take.

I believe with the connections that HEMOGENYX got they have already lined up doctors that are interested in giving this Phase I drug a go.

Then it is just a question if there are any Patients that are willing to take the risk.

Take a chance on HEMOGENYX (Sorry, couldn't resist getting an ABBA inspired quote in:-)

Because it is a risk.

It's a risk of time.

Their time.

Will this unknown experimental drug buy them more precious time with their loved ones?

Will this unknown experimental drug give them more comfort and fewer side effects?

Is this experimental drug from HEMOGENYX likely to be better than any other experimental drug or treatment that might be available?

If there are any risks worth contemplating and talking about at the moment, then these are the ones in my view.

I have made my bet, I have placed my money where my mouth is, and if I am right, then there are going to be a lot of winners.

Not least the Patient's lives who are going to be saved.

@HedgeHogarth

Although I take that it is a couple of years ago that your wife passed away, I would like to pass on my condolences, you know better late then never.

I appreciate the time you put into correcting the misinformation that some individuals post on here, what ever their motivation might be.

Personally I am afraid that it is more sinister then your suggestions, as I cannot fathom why any one would spend the time and effort on this share with a small turnover being traded daily and just a small % change.

@mryummy

I am afraid you are getting ahead of yourself.

Around the 2 pence mark per share the company would have a market cap around 100 million.

To justify that, it would have to be one hell of a gold find.

I am not saying, that won't be the case, but equally, I cannot say that it will be the case either, so I would advise caution hunting pies in the sky, although it is tempting with the current low share price and the number of shares £1000 can get you.

But don't forget there are more than 4.5 BILLION shares in circulation in this company.

I think there is money to be made here, but I very much doubt the share price will reach 20 pence per share without some sort of consolidation.

@JustHereForHemo

Your arguments do indeed show why it is so important that HEMO ensures just enough is said about CBR to keep the fire burning, but not so much that a competitor can easily decipher and overcome the obstacles and create a competing product.

And also why it is so important that Hemo spends all the possible time they have at its disposal on researching its invention and covering as many possible outcomes as it can possibly think of to ensure that other companies can only deal in this field in the next 20 years if they buy a licence from HEMOGENYX.

Now wouldn’t that be something?

And that is just one of the reasons, why I would not be in favour of a buyout.

At any price.

Yes, even £10 a share.

Admittedly, I get ahead of myself here, but I stand by it.

I honestly believe that if CBR can deliver what we hope and dream it can without severe side effects, then a market cap of 11 Billion is a joke.

Again admitted, it will take years and many trials to get to that stage, but I have patience, especially as I do not believe for a second, the share price would stay down here in the single pence region if and when we get the news we all want and so desire on CBR.

But first things first.

Hemo Car-T, is ready to get rolled out. There is just that little matter of IND to be sorted first and it is likely that it will be sorted in a matter of days or a few weeks at the most as it has been applied for.

If this product is effective (Hurray for Patients) then maybe it can be either cash generative before the end of 2024 or sold for a significant sum, which will allow the development of CBR.

Either case is desirable for me.

Especially keeping the product, ourselves and building a name in the medical field and consumers' mind.

We should hopefully be able to borrow money against our income or projected income.

I am not of the opinion that getting for instance 100 million here and now for HEMO Car-T is the best option, CBR can be proven to be safe and work for the income from HEMO Car-T.

It will take years, but it would take years anyway, even with 100 million in the bank account.

But I must admit that having 100 million in a bank account would undoubtedly have a positive effect on the share price.

But no matter what, if CBR works, if we want the maximum financial outcome, we do not get that as shareholders by selling the company to one of the big boys.

Collaboration YES.

Selling NO.

@catcatbar

I agree with the sentiment that no news is good news when it comes to CBR, insofar as to understand that had it utterly and completely failed with no hope of resurrection then it would have to be RNS'ed.

That is not to say that it therefor must have been plain sailing in the lab, they may have encountered issues, but if they have then they cannot have been of a magnetude that demands an RNS.

Personally, I hope everything has been progressing at a decent speed and accordingly to expectations while HEMO was focusing on HEMO Car-T.

Giving extra time in research is not a bad thing in my book, it improves the chances to discover either added benefits or unwished side effects.

But when it comes to your hopes of HEMO bringing an event forward time wise, I would not get my hopes up.

If history is anything to go by, it's not a bet that I would take.

But I am sure you can entrust them to comply with the rules, whatever they may be, so they do not loose their rights to CBR.